PRESS RELEASE published on 02/20/2025 at 18:30, 1 year 6 months ago Inside Information / Operations of the issuer (acquisitions, sales...) Theraclion secures financing of €6 million through a convertible bond loan with firm commitments from historical shareholders, Furui and Unigestion. CEO Martin Deterre highlights strategic priorities for revenue growth and FDA approval Financing Strategic Priorities FDA Approval Theraclion Convertible Bond Loan
BRIEF published on 02/07/2025 at 18:35, 1 year 7 months ago Publication of Theraclion's adjusted accounts for the first half of 2024 Treasury Theraclion Adjusted Accounts Focused Ultrasound Varicose Veins Walk
BRIEF published on 01/06/2025 at 19:06, 1 year 8 months ago Theraclion 2024 Review: Progress and Challenges Turnover Theraclion SONOVEIN® FDA Clinical Trial Product Maturity
BRIEF published on 10/30/2024 at 19:05, 1 year 10 months ago Theraclion: Results for the First Half of 2024 and Strategic Outlook Financial Results Theraclion SONOVEIN FDA America Marketing 2025
BRIEF published on 09/06/2024 at 18:35, 2 years ago Theraclion presents its achievements for the first half of 2024 FDA China R&D Theraclion SONOVEIN®
PRESS RELEASE published on 09/06/2024 at 18:30, 2 years ago Inside Information / Other news releases Theraclion reports strong mid-year achievements focusing on U.S. market access, R&D progress, and Chinese market entry. Key milestones include FDA pivotal study completion and international scientific recognition FDA China R&D Theraclion Achievements
Published on 09/18/2026 at 06:30, 1 hour 26 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 7 hours 1 minute ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 7 hours 31 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 9 hours 41 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/18/2026 at 07:15, 40 minutes ago Sandoz announces collaboration with mAbxience to expand patient access to life-enhancing biosimilar medicines
Published on 09/18/2026 at 07:00, 55 minutes ago Sandoz receives regulatory approval for generic semaglutide in Canada, paving way to expand patient access to key GLP-1 medicine
Published on 09/18/2026 at 06:45, 1 hour 10 minutes ago HUBER+SUHNER presents strategy and growth potential at Capital Market Day 2026
Published on 09/18/2026 at 05:30, 2 hours 25 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/17/2026 at 19:00, 12 hours 55 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 17:40, 14 hours 16 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 14 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
